SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/2 trial of i.v. citicoline (CDP-choline) in hospitalized SARS CoV-2-infected patients with hypoxemic acute respiratory failureSonal Pannu, Elliott D. Crouser, Philip Diaz et al.|Trials|2024Cited by 1
Addition of I.V. Citicoline to Standard of Care in Hospitalized COVID Patients with Acute Hypoxemic Respiratory Failure or ARDS: A Block-Randomized, Double-Blinded, Placebo-Controlled, Phase 1/2 Superiority TrialIan C. Davis, Elliott D. Crouser, Hayden R. Klemanski et al.|SSRN Electronic Journal|2025Cited by 0